Home

הכי מוקדם מחט סמינר pepscan presto bv גבריות גשר לחלל

Contact us | Pepscan
Contact us | Pepscan

What are oxytocin assays measuring? Epitope mapping, metabolites, and  comparisons of wildtype & knockout mouse urine - ScienceDirect
What are oxytocin assays measuring? Epitope mapping, metabolites, and comparisons of wildtype & knockout mouse urine - ScienceDirect

Pepscan...Enable life-improving breakthroughs by mastering peptides
Pepscan...Enable life-improving breakthroughs by mastering peptides

Pepscan Presto | Public Marketplace
Pepscan Presto | Public Marketplace

Development of a Modular Vaccine Platform for Multimeric Antigen Display  Using an Orthobunyavirus Model
Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model

Collaborative Research Leads To New Understanding Of Biomarkers - Drug  Discovery World (DDW)
Collaborative Research Leads To New Understanding Of Biomarkers - Drug Discovery World (DDW)

Pepscan Presto B.V. Lelystad - Oozo.nl
Pepscan Presto B.V. Lelystad - Oozo.nl

Pepscan Presto B.v. - Lelystad 8243 RC (Lelystad), Zuidersluisweg 2 ,
Pepscan Presto B.v. - Lelystad 8243 RC (Lelystad), Zuidersluisweg 2 ,

Company | Pepscan
Company | Pepscan

What are oxytocin assays measuring? – Arbor Assays
What are oxytocin assays measuring? – Arbor Assays

bcyc-20201231ex102314767001.jpg
bcyc-20201231ex102314767001.jpg

Biosensors | Free Full-Text | Microsphere Peptide-Based Immunoassay for the  Detection of Recombinant Bovine Somatotropin in Injection Preparations
Biosensors | Free Full-Text | Microsphere Peptide-Based Immunoassay for the Detection of Recombinant Bovine Somatotropin in Injection Preparations

Isolation and characterization of phage display-derived scFv antibodies  against human parechovirus 1 VP0 protein | Scientific Reports
Isolation and characterization of phage display-derived scFv antibodies against human parechovirus 1 VP0 protein | Scientific Reports

Assays for oxytocin detection
Assays for oxytocin detection

Conditions Générales | Pepscan
Conditions Générales | Pepscan

Mutational analysis of protein folding inside the ribosome exit tunnel -  Farías‐Rico - 2017 - FEBS Letters - Wiley Online Library
Mutational analysis of protein folding inside the ribosome exit tunnel - Farías‐Rico - 2017 - FEBS Letters - Wiley Online Library

Histone H3 clipping is a novel signature of human neutrophil extracellular  traps
Histone H3 clipping is a novel signature of human neutrophil extracellular traps

Pepscan General Terms and Conditions
Pepscan General Terms and Conditions

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and  substantial CD8+ T cell activation in COVID-19 patients | Science Immunology
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients | Science Immunology

Kinome profiling of non-canonical TRAIL signaling reveals  RIP1–Src–STAT3-dependent invasion in resistant non-small cell lung
Kinome profiling of non-canonical TRAIL signaling reveals RIP1–Src–STAT3-dependent invasion in resistant non-small cell lung

Pepscan Presto | Public Marketplace
Pepscan Presto | Public Marketplace

Investigation of the marine compound spongistatin 1 links the inhibition of  PKC translocation to nonmitotic effects of tubulin a
Investigation of the marine compound spongistatin 1 links the inhibition of PKC translocation to nonmitotic effects of tubulin a

Pepscan – Dulisco
Pepscan – Dulisco

14-3-3 proteins inactivate DAPK2 by promoting its dimerization and  protecting key regulatory phosphosites | Communications Biology
14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites | Communications Biology

BMC Biochemistry
BMC Biochemistry

Assays for oxytocin detection
Assays for oxytocin detection

Frontiers | Three doses of BNT162b2 COVID-19 mRNA vaccine establish  long-lasting CD8+ T cell immunity in CLL and MDS patients
Frontiers | Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients